The Lancet Diabetes & Endocrinology
Papers 1575
1 page of 158 pages (1,575 results)
#1Louise J. Maple-Brown (CDU: Charles Darwin University)H-Index: 18
#2Sian Graham (CDU: Charles Darwin University)H-Index: 2
Last. Wicklow Brandy A (UM: University of Manitoba)H-Index: 16
view all 4 authors...
#1David Z.I. Cherney (UHN: University Health Network)H-Index: 31
#2Claire C. J. Dekkers (UG: University of Groningen)H-Index: 3
Last. Heather N. Reich (UHN: University Health Network)H-Index: 29
view all 15 authors...
Summary Background SGLT2 inhibition decreases albuminuria and reduces the risk of kidney disease progression in patients with type 2 diabetes. These benefits are unlikely to be mediated by improvements in glycaemic control alone. Therefore, we aimed to examine the kidney effects of the SGLT2 inhibitor dapagliflozin in patients with proteinuric kidney disease without diabetes. Methods DIAMOND was a randomised, double-blind, placebo-controlled crossover trial done at six hospitals in Canada, Malay...
1 CitationsSource
#1Stefan Groeneweg (EUR: Erasmus University Rotterdam)H-Index: 3
#2Ferdy S van Geest (EUR: Erasmus University Rotterdam)H-Index: 1
Last. Ingrid M. van Beynum (EUR: Erasmus University Rotterdam)H-Index: 8
view all 88 authors...
Summary Background Disordered thyroid hormone transport, due to mutations in the SLC16A2 gene encoding monocarboxylate transporter 8 (MCT8), is characterised by intellectual and motor disability resulting from cerebral hypothyroidism and chronic peripheral thyrotoxicosis. We sought to systematically assess the phenotypic characteristics and natural history of patients with MCT8 deficiency. Methods We did an international, multicentre, cohort study, analysing retrospective data from Jan 1, 2003, ...
1 CitationsSource
#1Hessa Al-Kandari (Farwaniya Hospital)H-Index: 5
#2Dalia Al-Abdulrazzaq (Kuniv: Kuwait University)H-Index: 4
Last. Fahd Al-MullaH-Index: 33
view all 4 authors...
#1Neda Razaz (KI: Karolinska Institutet)H-Index: 3
#2Eduardo Villamor (UM: University of Michigan)H-Index: 42
Last. Sven Cnattingius (KI: Karolinska Institutet)H-Index: 86
view all 5 authors...
Summary Background Maternal overweight and obesity might increase risks of adiposity and cardiovascular and metabolic diseases in offspring. We examined associations between maternal overweight and obesity severity and risk of cardiovascular diseases in young offspring. Methods In this population-based cohort study, we used data from live singleton births recorded in the Swedish Medical Birth Register. We calculated maternal BMI in early pregnancy from self-reported height and weight measurement...
1 CitationsSource
#1Hillel K Sternlicht (WSU: Wayne State University)
#2George L. Bakris (U of C: University of Chicago)H-Index: 105
#1Jane Speight (Deakin University)H-Index: 27
#2Timothy Skinner (UCPH: University of Copenhagen)H-Index: 34
Last. Andrew J.M. Boulton (Manchester Royal Infirmary)H-Index: 87
view all 5 authors...
#1Romy Gaillard (Erasmus University Medical Center)H-Index: 7
Top fields of study
Internal medicine
Type 2 diabetes
Diabetes mellitus